Helpful microbes that combat harmful pathogens could be the answer to rising antimicrobial resistance—particularly within ...
The combination drug ceftazidime-avibactam (CZA) is a last line of defense against the common Pseudomonas aeruginosa hospital ...
Spero Therapeutics (SPRO) gets a Buy on immunology pivot, FDA-approved Utebzi and $105M royalty deal funding SP001. Click ...
Wearable devices have transformed how people track exercise, sleep, heart rate and other vital signs. Researchers at King ...
Faster and more effective ways to treat Pseudomonas aeruginosa, a bacterium identified by the World Health Organization (WHO) ...
The global antibiotic pipeline has historically faced substantial attrition, with numerous clinical candidates failing to achieve FDA approval despite ...
Alison Holmes is making plans. As the Director of the Fleming Initiative, a global partnership led by Imperial College London ...
India’s National Pharmaceutical Pricing Authority (NPPA) has announced price reductions for more than 30 drugs and biological ...
When antibiotics attack microbes, their stressed neighbors ship them proteins to help them survive, new work suggests.
Cyclosporiasis, a parasitic illness that causes explosive diarrhea, is still surging throughout the country. As of Tuesday, ...
Resistance to the main drug in front-line malaria treatments is becoming more widespread across East Africa, according to new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results